SDC for Lung Cancer Patients Treated With Curative Primary or Postoperative Radiotherapy or Chemoradiation
Conditions
Lung Cancer
Conditions: official terms
Lung Neoplasms
Study Type
Observational
Study Phase
N/A
Study Design
Observational Model: Cohort, Time Perspective: Prospective
Overall Status
Recruiting
Summary
Introducing standardized data collection (SDC) for lung cancer patients to improve the performance of the prediction models.
Detailed Description
All patients planned for curative primary or postoperative radiotherapy can be included. Patients will be treated according to the institutional protocol. It is optional to collect a saliva sample for genetic profiling.

Follow up at five time points:

- 2 weeks after RT

- 3 months after RT

- 6 months after RT

- 12 months after RT

- 24 months after RT

At these time points, toxicity will be assessed. In addition, patients will receive a short questionnaire by mail at eight time points.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:

- All patients planned for curatively intended radiotherapy or postoperative radiotherapy

- Recurrent disease

Exclusion Criteria:

- All patients planned for palliative radiotherapy
Location
MAASTRO clinic
Maastricht, Netherlands
Status: Recruiting
Contact: Chantal Overhof-Wedick - +31 88 44 55 686 - chantal.overhof@maastro.nl
Start Date
June 2013
Completion Date
March 2016
Sponsors
Maastricht Radiation Oncology
Source
Maastricht Radiation Oncology
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page